These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 8087425

  • 21. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.
    Västrik I, Mäkelä TP, Koskinen PJ, Saksela K, Alitalo K.
    Princess Takamatsu Symp; 1991; 22():307-18. PubMed ID: 1668890
    [Abstract] [Full Text] [Related]

  • 22. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
    Vervoorts J, Lüscher B.
    Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451
    [Abstract] [Full Text] [Related]

  • 23. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X, Giap C, Lazo JS, Prochownik EV.
    Oncogene; 2003 Sep 18; 22(40):6151-9. PubMed ID: 13679853
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L, Helmer-Citterich M, Sacco A, Jucker R, Cesareni G, Nasi S.
    Oncogene; 1998 Nov 12; 17(19):2463-72. PubMed ID: 9824157
    [Abstract] [Full Text] [Related]

  • 26. max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors.
    Berberich S, Hyde-DeRuyscher N, Espenshade P, Cole M.
    Oncogene; 1992 Apr 12; 7(4):775-9. PubMed ID: 1565473
    [Abstract] [Full Text] [Related]

  • 27. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
    Sauvé S, Tremblay L, Lavigne P.
    J Mol Biol; 2004 Sep 17; 342(3):813-32. PubMed ID: 15342239
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence.
    Giorello L, Clerico L, Pescarolo MP, Vikhanskaya F, Salmona M, Colella G, Bruno S, Mancuso T, Bagnasco L, Russo P, Parodi S.
    Cancer Res; 1998 Aug 15; 58(16):3654-9. PubMed ID: 9721875
    [Abstract] [Full Text] [Related]

  • 29. Max and c-Myc/Max DNA-binding activities in cell extracts.
    Littlewood TD, Amati B, Land H, Evan GI.
    Oncogene; 1992 Sep 15; 7(9):1783-92. PubMed ID: 1501888
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. c-Myc and Max interactions in quiescent and mitogen-stimulated primary hepatocytes.
    Skouteris GG, Schröder CH.
    Exp Cell Res; 1996 Jun 15; 225(2):237-44. PubMed ID: 8660911
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
    Larsson LG, Bahram F, Burkhardt H, Lüscher B.
    Oncogene; 1997 Aug 07; 15(6):737-48. PubMed ID: 9264414
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.